All NewsEditorialCase studiesFeatured inEventResearchGeneMateEmployee Profile: Francisca Lameiras 02-12-2022 Employee Profile: Helena Silva Cascales 15-11-2022 GeneMateNew guidelines for hereditary breast cancer 14-09-2022 EditorialMonogenic vs Polygenic Inheritance 28-07-2022 Types of inheritance, terms, and genetic testingEditorialIs blood cancer hereditary? 22-07-2022 NewsFinally Kristina was able to get tested 29-06-2022 After having lost her mom and maternal grandmother to breast cancer, Kristina wondered about her hereditary risk. Kristina got tested with GeneMate.NewsiCellate Medical expands its accredited lab 23-06-2022 iCellate has recently finalized the expansion of its lab for the accredited service GeneMate®. GeneMate® is a service that is used to analyze an…NewsiCellate Medical secures 20 MSEK in new funding 19-05-2022 iCellate Medical has closed a successful round of financing, raising 20 MSEK from a combination of existing and new investors.NewsiCellate launches collaboration with football player Olivia Schough 21-04-2022 Cancer diagnostics company iCellate Medical AB announces collaboration with football star Olivia Schough. Olivia shares her story of hereditary cancer…NewsProject ELEVATE initiates clinical trial for development of novel cancer diagnostics 22-02-2022 February 10, 2022. Elthera AG, iCellate Medical AB, Targos Molecular Pathology GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental…GeneMateWhich genetic variants cause disease? 10-02-2022 Changes in our DNA occur all of the time. Many are harmless, while others cause disease.NewsiCellate Expands Headquarters 19-01-2022 Employee Profile: André Nobre 14-01-2022 GeneMateCalculate your risk 12-01-2022 What is the likelihood that you carry a pathogenic variant?Employee Profile: Iohn Ryott 06-12-2021 GeneMateMapping your family cancer history 23-11-2021 The importance of family cancer history and how to map itEmployee Profile: Sabina Botic 19-11-2021 Employee Profile: Emelie Berglund 08-11-2021 GeneMateHereditary stomach cancer 08-07-2021 Stomach cancer is the fifth most common cancer in the world, and 10-20% is hereditaryNewsGeneMate® now a part of global rare disease database and resource Orphanet 01-07-2021 Increased visibility of hereditary cancer risk can lead to increased opportunities for cancer prevention and early detectionNewsJob Opening: Clinical Molecular Geneticist 29-06-2021 Come join us!GeneMateWhat to expect from your GeneMate® test 17-06-2021 GeneMateBehind the scenes of GeneMate® 10-06-2021 GeneMateThe importance of informing family members of a positive result 17-05-2021 All first-degree relatives of a carrier have a 50% risk of themselves being a carrierGeneMateHereditary melanoma 06-05-2021 Melanoma is the most rapidly increasing cancer in Sweden and 10-15% of all cases are hereditaryGeneMateWhich genes does GeneMate® test and why? 03-05-2021 Our clinically actionable selection of genes gives you a better shot at prevention.GeneMateHereditary prostate cancer 27-04-2021 1 in 5 Swedish men will be diagnosed with prostate cancer. Guidelines for the identification of hereditary prostate cancer are now expanded.GeneMateHereditary cancer: 97% of all carriers remain unidentified 23-04-2021 Family history-based testing identifies some, misses manyGeneMatePolyposis syndromes 15-04-2021 Polyposis' cause, associated cancer types, and risk-reducing measuresNewsiCellate’s lab receives ISO 15189 certification by Swedac 13-04-2021 iCellate is the only Swedish company that holds an ISO 15189 certification within cancer diagnostics.GeneMateHereditary ovarian cancer 03-03-2021 15-20% of all ovarian cancer is hereditaryGeneMateLynch Syndrome 24-02-2021 Lynch syndrom is caused by hereditary pathogenic variants and increases the risk of several different cancer typesGeneMateThings to consider prior to genetic testing 15-02-2021 EditorialThis is our mission 12-02-2021 GeneMateHereditary breast cancer 03-02-2021 15-20% of all breast cancer is hereditary EditorialR&D Update: project ELEVATE 14-01-2021 GeneMateHereditary colorectal cancer 01-12-2020 One third of all colorectal cancer is hereditaryNewsElthera-led consortium initiates development of novel cancer diagnostics and therapeutics 24-11-2020 NewsiCellate has been selected to participate in Novartis' Techcare program 07-01-2020 NewsStudy presented at KICancer - StratCan 23-09-2019 ResearchThe early detection of cancer study (ICELLATE1) – published in the Journal of Integrative Oncology 03-10-2018 ResearchGroundbreaking pan-cancer screening study published 01-06-2018 NewsiCellate enters partnership with RCC Stockholm-Gotland 18-12-2017 NewsiCellate Medical closes 15 million SEK second round of funding 19-10-2016 NewsiCellate Medical receives orders for clinical CTC services from major institutions and adds valuable sequencing competence to the company 15-05-2016
![[Translate to English:]](https://icellate.se/fileadmin/_processed_/7/4/csm_AdobeStock_68410295_c6050b13e4.jpg "[Translate to English:]")
